Skip to main content

Quzyttir FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 7, 2020.

FDA Approved: Yes (First approved October 4, 2019)
Brand name: Quzyttir
Generic name: cetirizine hydrochloride
Dosage form: Injection
Company: TerSera Therapeutics LLC
Treatment for: Urticaria

Quzyttir (cetirizine hydrochloride) is a histamine-1 (H1) receptor antagonist indicated for the treatment of acute urticaria in adults and children 6 months of age and older.